Correlations of evoked potentials with MR imaging and MR spectroscopy in multiple sclerosis.
The current state-of-the-art imaging technique in multiple sclerosis (MS) is magnetic resonance (MR) imaging. With improved imaging technology, MR spectroscopy offers the capacity to identify those chemical changes associated with MS and promises to enhance our ability to understand this disease. Physiologic function in the central nervous system can be measured using evoked potentials. This article analyzes the correlation between these two techniques.
Kraft
G H
GH
Department of Rehabilitation Medicine, and Electrodiagnostic Medicine, University of Washington, Seattle, USA.
Richards
T L
TL
Heide
A C
AC
D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000032:analysis; D001921:Brain / Q000378:metabolism / Q000503:physiopathology; D002794:Choline / Q000032:analysis; D003401:Creatine / Q000032:analysis; D005071:Evoked Potentials / Q000502:physiology*; D005073:Evoked Potentials, Somatosensory / Q000502:physiology; D005074:Evoked Potentials, Visual / Q000502:physiology; D006801:Humans; D007773:Lactates / Q000032:analysis; D008055:Lipids / Q000032:analysis; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000378:metabolism / Q000503:physiopathology; D009431:Neural Conduction / Q000502:physiology
D007773:Lactates; D008055:Lipids; D001224:Aspartic Acid; C000179:N-acetylaspartate; D003401:Creatine; D002794:Choline